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     BSTRACT
A Belgian population of ten breeds with a low to moderately low genetic diversity or which 
are relatively popular in Belgium, i.e. Bichon frise, Bloodhound, Bouvier des Flandres, Boxer, 
Cavalier King Charles spaniel, Irish setter, Papillon, Rottweiler, Golden retriever and Labra-
dor retriever, was genotyped for all potentially relevant disease-causing variants known at the 
start of the study. In this way, the frequency was estimated for 26 variants in order to improve 
breeding advice. Disorders with a frequency high enough to recommend routine genotyping in 
breeding programs are (1) degenerative myelopathy for the Bloodhound, (2) arrhythmogenic 
right ventricular cardiomyopathy and degenerative myelopathy for Boxers, (3) episodic falling 
syndrome and macrothrombocytopenia for the Cavalier King Charles spaniel, (4) progressive 
retinal atrophy rod cone dysplasia 4 for the Irish setter (5) Golden retriever progressive retinal 
atrophy 1 for the Golden retriever and (6) exercise induced collapse and progressive rod-cone 
degeneration for the Labrador retriever. To the authors’ knowledge, in this study, the presence 
of a causal mutation for a short tail in the Bouvier des Flandres is described for the first time.
SAMENVATTING
De Belgische populatie van tien hondenrassen (de bichonfrisé, sint-hubertushond, Vlaamse koe-
hond, boxer, cavalier-kingcharlesspaniël, Ierse setter, het vlinderhondje, de rottweiler, golden retriever 
en labrador-retriever), waarvan de genetische diversiteit in België laag tot middelmatig laag is of die 
relatief populair zijn, werd gegenotypeerd voor ziekteveroorzakende mutaties die potentieel relevant 
zijn voor deze rassen. Op deze manier werd de frequentie van 26 mutaties geschat om zo gerichter 
fokadvies te kunnen geven. Aandoeningen waarvan de frequentie hoog genoeg ligt om routine-genoty-
pering aan te raden in fokprogramma’s zijn (1) degeneratieve myelopathie voor de sint-hubertushond, 
(2) “arrhythmogenic right ventricular cardiomyopathy” en degeneratieve myelopathie voor boxers, (3) 
“episodic falling syndrome” en macrothrombocytopenie voor de cavalier-kingcharlesspaniël (4) pro-
gressieve retina-atrofie “rod-cone” dysplasie 4 voor de Ierse setter, (5) golden retriever progressieve 
retina-atrofie 1 voor de golden retriever en (6) “exercise induced collapse” en progressieve “rod-cone” 
degeneratie voor de labrador-retriever. De aanwezigheid van de oorzakelijke mutatie voor een korte 
staart bij de Vlaamse koehond wordt hier volgens de auteurs voor het eerst beschreven.
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INTRODUCTION
A low genetic diversity prevails in several dog 
breeds. Consequently, high prevalences of genetic 
disorders may occur (Calboli et al., 2008; Leroy et 
al., 2006). In order to improve this situation, a good 
knowledge of the disorders in each breed is neces-
sary as well as of the prevalence in a population (Mc-
Greevy and Nicholas, 1999). 
A total of seventeen dog breeds were involved in 
the entire study. Each breed population was tested for 
potentially relevant disease-causing variants, more 
specifically those that have been described in the cor-
responding breed and that are available in the public 
domain. In part 2, the results obtained for two retriever 
breeds (Golden and Labrador retriever) and eight 
other breeds (the Bichon frise, Bloodhound, Bouvier 
des Flandres, Boxer, Cavalier King Charles spaniel, 
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Disorder: Arrhythmogenic right ventricular cardiomyopathy (ARVC) dbSNP ID:  OMIA ID: 000878-9615
Gene symbol: STRN Inheritance: Autosomal dominant, ss1961068750 Reference: Meurs et al., 2010
 incomplete penetrance  
Assay: PCR with F/R primers and sequence analysis with R primer Ta: 64°C Amplicon: 239 bp
Primers: F: 5’-acaaaacagtaaaatgcacctatggtt-3’; R: 5’-tgactctcattccttcagtattcttgc-3’   
Disorder: Canine leukocyte adhesion deficiency type 1 (CLAD1) dbSNP ID: OMIA ID: 000595-9615
Gene symbol: ITGB2 Inheritance: Autosomal recessive ss1961068757 Reference: Kijas et al., 1999
Assay: PCR with F/R primers and sequence analysis with F primer Ta: 65°C Amplicon: 344 bp
Primers: F: 5’-ggaccctccttctccaccac-3’; R: 5’-gcctccccggaaacagagt-3’   
Disorder: Centronuclear myopathy (CNM) dbVar ID: OMIA ID: 001374-9615
Gene symbol: PTPLA Inheritance: Autosomal recessive nsv1397888 Reference: Pelé et al., 2005
Assay: PCR with F/R primers and gel electrophoresis Ta: 64°C Amplicon: Wt: 115 bp; 
                                         Mt: 364 bp
Primers: F: 5’- tggttctagctattgccatggtacg -3’; R: 5’- acctcaagcaaggcaaatgtctg -3’   
Disorder: Degenerative myelopathy (DM) dbSNP ID: OMIA ID: 000263-9615
Gene symbol: SOD1 Inheritance: Autosomal recessive ss1961068758 Reference: Awano et al., 2009
Assay: qPCR with dual labeled probes  Ta: 56°C Amplicon: 192 bp
Primers: F: 5’-cttccactttcttgtgattg-3’  Probes: Wt: HEX-cgccttcagtcagcc-BHQ1
                R: 5’-caccttgtgtattatctccaa-3’                Mt: TR-cgcctttagtcagccc-BHQ2
                
Disorder: Duchenne type muscular dystrophy cavalier (DMD-C) dbSNP ID: OMIA ID: 001081-9615
Gene symbol: DMD Inheritance: X-linked recessive ss1961068760 Reference: Walmsley et al., 2010
Assay: PCR-RFLP with AccI  Ta: 64°C Amplicon: 752 bp
Primers: F: 5’-aatatttgtagggtggttggctaaaataat-3’ Fragment lengths: Wt: 303/243/206; Mt: 546/206
                R: 5’-taccttcggccccagaaaag-3’  
Disorder: Duchenne type muscular dystrophy Golden retriever (DMD-GR) dbSNP ID: OMIA ID: 001081-9615
Gene symbol: DMD Inheritance: Autosomal recessive ss1961068761 Reference Sharp et al., 1992
Assay: PCR with F/R primers and sequence analysis with F primer Ta: 60°C Amplicon: 235 bp
Primers: F: 5’-aatgatgggcatgggttg-3’; R: 5’-ccagaaatgtaccgaccttca-3’   
Disorder: Duchenne type muscular dystrophy rottweiler (DMD-R) dbSNP ID: OMIA ID: 001081-9615
Gene symbol: DMD Inheritance: X-linked recessive ss1961068762 Reference: Winand et al., 1994
Assay: PCR-RFLP with PsiI  Ta: 64°C Amplicon: 434 bp
Primers: F: 5’-agcatttcttttcatctcatttcacag-3’ Fragment lengths: Wt: 308/126; Mt: 194/126/114
                R: 5’-agcattccttctcaccaataatctca-3’ 
Disorder: Episodic falling syndrome (EFS) dbVar ID: OMIA ID: 001592-9615
Gene symbol: BCAN Inheritance: Autosomal recessive nsv1397889 Reference: Gill et al., 2012
Assay: PCR with F/R1/R2 primers and gel electrophoresis Ta: 64°C Amplicon: Wt: 393 bp;
Primers: F: 5’-aaggtcttacacctgcaatgaatag-3’; R1: 5’-agcaaatgtaaagtcctgtgaccat-3’ ;               Mt: 273 bp
                R2: 5’-agttcacattgtgctctctctactg-3’
   
Disorder: Exercise induced collapse (EIC) dbSNP ID: OMIA ID: 001466-9615
Gene symbol: DNM1 Inheritance: Autosomal recessive ss1961068747 Reference: Patterson et al., 2008
Assay: PCR-RFLP with SmlI  Ta: 64°C Amplicon: 232 bp
Primers: F: 5’-ggctggttgcccctgactt-3’  Fragment lengths: Wt: 205/27; Mt: 113/92/27
                R: 5’-ttttgttttccttttccccaggcttgagttccttacctg-3’  
Disorder: Globoid cell leukodystrophy (GCL) dbVar ID: OMIA ID: 000578-9615
Gene symbol: GALC Inheritance: Autosomal recessive nsv1397890 Reference: 
   McGraw & Carmichael, 2006
Assay: PCR with F/R primers and gel electrophoresis Ta: 64°C Amplicon: 
   Wt: 168 bp; Mt: 246 bp
Primers: F: 5’-cacgtctgccttttcctatttcca-3’; R: 5’-ggttcaatatgcggcccaag-3’   
Disorder: Golden retriever progressive retinal atrophy 1 (GR-PRA 1) dbSNP ID: OMIA ID: 001572-9615
Gene symbol: SLC4A3 Inheritance: Autosomal recessive ss1961068759 Reference: Downs et al., 2011
Assay: PCR with F/R primers and sequence analysis with F primer Ta: 64°C Amplicon: 264 bp
Primers: F: F: 5’-gtcgtggaatactgttgcctggt-3’; R: 5’-gccgtgttgggctggttc-3’   
Disorder: Hyperuricosuria (HUU)  dbSNP ID: OMIA ID: 001033-9615
Gene symbol: SLC2A9 Inheritance: Autosomal recessive ss1961068738 Reference: 
   Bannasch et al., 2008
Assay: qPCR with dual labeled probes  Ta: 63°C Amplicon: 101 bp
Primers: F: 5’-ccaaggagatccgtggc -3’  Probes: Wt: FAM-ccatcttcatctgcatcggtgt-BHQ1;
                R: 5’-cttccccagcagctcag -3’                 Mt: TR-catcttcatcttcatcggtgtgttc-BHQ2
Table 1. Overview of the performed DNA tests. Ta indicates the annealing temperature, bp indicates base pairs and F/R 
indicates the forward/reverse primer. TR indicates Texas Red.
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Disorder: Mucopolysaccharidosis I (MPS I) dbSNP ID: OMIA ID: 000664-9615
Gene symbol: IDUA Inheritance: Autosomal recessive ss1961068739 Reference: Menon et al., 1992
Assay: PCR with F/R primers and sequence analysis with R primer Ta: 68°C Amplicon: 433 bp
Primers: F: 5’-gacccggaggcggaacc-3’; R: 5’-ggacggccgaggtcacg-3’   
Disorder: Macrothrombocytopenia (MTC) dbSNP ID: OMIA ID: 001001-9615
Gene symbol: TUBB1 Inheritance: Autosomal recessive ss1961068754 Reference: Davis et al., 2008
Assay: PCR with F/R primers and sequence analysis with F primer Ta: 60°C Amplicon: 278 bp
Primers: F: 5’-cctggtgtccctgaccatga-3’; R: 5’-ggccccggaagatgcag-3’   
Disorder: Narcolepsy (NA)  dbSNP ID: OMIA ID: 000703-9615
Gene symbol: HCRTR2 Inheritance: Autosomal recessive ss1961068748 Reference: Lin et al., 1999
Assay: PCR with F/R primers and sequence analysis with F primer Ta: 64°C Amplicon: 382 bp
Primers: F: 5’-ccacacggaagacagagagacc-3’; R: 5’-ctccagttcctacaattttcactttcc-3’   
Disorder: Osteogenesis imperfecta (OI)  dbSNP ID: OMIA ID: 000754-9615
Gene symbol: COL1A1 Inheritance: Autosomal recessive ss1961068756 Reference: Campbell et al., 2000
Assay: PCR with F/R primers and sequence analysis with F primer Ta: 64°C Amplicon: 282 bp
Primers: F: 5’- agggcgtgcgtggtga -3’; R: 5’- ccctgtgggaggcagaaca -3’   
Disorder: Progressive retinal atrophy (PRA) dbSNP ID: OMIA ID: 000830-9615
Gene symbol: CNGB1 Inheritance: Autosomal recessive ss1961068735 Reference: Ahonen et al., 2013
Assay: PCR-RFLP with AluI  Ta: 64°C Amplicon: 287 bp
Primers: F: 5’-acgctcggcaaaccgcag-3’  Fragment lengths: Wt: 206/45/36;
                R: 5’-acagagaaagcaaagacacccgtga-3’                                  Mt: 116/95/45/36
   
Disorder: Progressive rod-cone degeneration (PRCD) dbSNP ID: OMIA ID: 001298-9615
Gene symbol: PRCD Inheritance: Autosomal recessive ss1961068746 Reference: Zangerl et al., 2006
Assay: PCR-RFLP with ApaLI  Ta: 60°C Amplicon: 129 bp
Primers: F: 5’-aggatgggcagcagtgg-3’;  Fragment lengths: Wt: 97/32 bp; Mt: 129 bp
                R: 5’-ttttttttttgctgagtacgaagagggtggt -3’  
Disorder: Rod-cone dysplasia 1 (RCD1)  dbSNP ID: OMIA ID: 000882-9615
Gene symbol: PDE6B Inheritance: Autosomal recessive ss1961068741 Reference: Suber et al., 1993
Assay: PCR with F/R primers and sequence analysis with F primer Ta: 58°C Amplicon: 122 bp
Primers: F: 5’-ttcccgtttccacgaaga-3’; R: 5’-gctgcttctcctcctccag-3’   
Disorder: Rod-cone dysplasia 4 (RCD4)  dbSNP ID: OMIA ID: 001575-9615
Gene symbol: C17H2orf71 Inheritance: Autosomal recessive ss1961068751 Reference: Downs et al., 2012
Assay: PCR with F/R primers and sequence analysis with F primer Ta: 64°C Amplicon: 358 bp
Primers: F: 5’-acacgccgagcagacaggag-3’; R: 5’-aggacgcgggccagaagag-3’   
Disorder: Recessive dystrophic epidermolysis bullosa (RDEB) dbSNP ID: OMIA ID: 000341-9615
Gene symbol: COL7A1 Inheritance: Autosomal recessive ss1961068752 Reference: Baldeschi et al., 2003
Assay: PCR-RFLP with HaeIII  Ta: 64°C Amplicon: 304 bp
Primers: F: 5’-tggtcccaagggtgaacgtg-3’;  Fragment lengths: Wt: 105/66/49/48/18/9/9 bp;
                R: 5’-aaatgccccagccctgctc-3’                                   Mt: 171/49/48/18/9/9 bp 
Disorder: Short tail (ST)  dbSNP ID: OMIA ID: 000975-9615
Gene symbol: T Inheritance: Autosomal dominant ss1961068734 Reference: Haworth et al., 2001
Assay: PCR-RFLP with BstEII  Ta: 64°C Amplicon: 343 bp
Primers: F: 5’-tgagcgccgtggagagcg-3’  Fragment lengths:  Wt: 184/159;
                R: 5’-cccagaaaacccagagagtgacga-3’                                   Mt: 184/128/31 
Disorder: von Willebrandt disease type 1 (VWD1) dbSNP ID: OMIA ID: 001057-9615
Gene symbol: VWF Inheritance: Autosomal recessive ss1961068765 Reference: Brewer et al., 1998
Assay: PCR with F/R primers and sequence analysis with F primer Ta: 65°C Amplicon: 287 bp
Primers: F: 5’-cgaggcaccatctaccctgtg-3’; R: 5’-tcacccaacctcagtcctctcc-3’   
Disorder: X-linked hypohydrotic ectodermal dysplasia (XHED) dbSNP ID: OMIA ID: 000543-9615
Gene symbol: EDA Inheritance: X-linked recessive ss1961068763 Reference: Casal et al., 2005
Assay: PCR-RFLP with ScrFI  Ta: 64°C Amplicon: 194 bp
Primers: F: 5’-tcccttcttgttgcctctcacc-3’  Fragment lengths: Wt: 146/25/23; Mt: 169/25
                R: 5’-ccatcttcaccgcaatcttctg-3’   
Disorder: X-linked myotubular myopathy (XLMTM) dbSNP ID: OMIA ID: 001508-9615
Gene symbol: MTM1 Inheritance: X-linked recessive ss1961068764 Reference: Beggs et al., 2010
Assay: qPCR with dual labeled probes  Ta: 57°C Amplicon: 181 bp
Primers: F: 5’- tgcggaggacatagta -3’  Probes: Wt: FAM- aacttttcttcgtttagaaatgc -BHQ1;
                R: 5’- gcggcttactgactta -3’                 Mt: TR- aacttttcttcttttagaaatgca -BHQ2 
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Irish setter, Papillon and Rottweiler) are highlighted. 
The results of seven shepherd breeds were discussed 
in part 1. 
MATERIALS AND METHODS
Breed selection
The chosen breeds for this research were based on 
a study examining the genetic diversity of 23 breeds 
(Wijnrocx et al., 2012). The more popular breeds and 
breeds with the lowest genetic diversity, for which 
at least two DNA tests were available at the start of 
the study, were chosen for inclusion in this frequency 
study. One exception was the Bloodhound, for which 
only the presence of degenerative myelopathy was 
tested.
Samples and DNA extraction
Whole blood samples collected in EDTA-tubes 
were used. They originated from a pool of samples 
(stored at -20°C) delivered by veterinarians, animal 
clinics, independent breeders and breeding associa-
tions all over Belgium for routine genotyping, making 
the sample as representative as possible for the Bel-
gian population. To the best of the authors’ ability, 
closely related animals (relation >12.5%) were ex-
cluded in order to keep the bias as low as possible, 
but in some cases sufficient information was lacking 
or the population size was too small. The aimed mini-
mum of 50 samples per breed was not reached for the 
Bichon frise (n = 27), for the Bloodhound (n = 27) and 
for the Papillon (n = 39).
One hundred µl of each sample was washed with 
500 µl Tris-HCl-EDTA until a clean pellet of white 
blood cells remained. The cells were resuspended in a 
lysis buffer with proteinase K, and DNA was released 
during an incubation kept at 56 °C for 45 minutes. Af-
terwards, the enzyme was inactivated at 95 °C during 
a ten-minutes incubation.
Disorders and DNA tests
In total, 26 different tests were performed. The 
assays were validated by sequencing, which is the 
golden standard. When applicable, the assays were 
later performed with quicker, cheaper and/or easier 
techniques (PCR(-RFLP) followed by gel electropho-
resis or qPCR with dual labeled probes). Details of the 
mutations and the performed (alternative) tests can be 
found in Table 1. The Hardy-Weinberg (H-W) equi-
librium was calculated for each disorder, as well as 
the allele frequencies.
PCR-sequencing
All assays were first validated through PCR fol-
lowed by sequencing. This was done in the same man-
ner as explained in part 1.
PCR-gel electrophoresis
For the detection, if INDELs (insertions and/or 
deletions) longer than 20 bp, a PCR was performed 
Table 2. All DNA tests with at least one mutation found in the tested population (+) and with no mutation in the cor-
responding breed (-). Disorders indicated with a “*” should be routinely tested in the corresponding breed.
Breed  Outcome  Test(s)
Bichon frise + Degenerative myelopathy (DM)
  - X-linked hypohydrotic ectodermal dysplasia (XHED)
Bloodhound + DM*
Bouvier des Flandres + Exercise induced collapse (EIC), short tail (ST)
Boxer  + Arrhythmogenic right ventricular cardiomyopathy* (ARVC), DM*
Cavalier King + Episodic falling syndrome* (EFS), macrothrombocytopenia* (MTC)
Charles spaniel - Duchenne muscular dystrophy (DMD-C)
Golden retriever + Golden retriever progressive retinal atrophy 1* (GR-PRA),
   progressive rod-cone degeneration (PRCD)
  - DM, Duchenne muscular dystrophy (DMD-GR), osteogenesis imperfecta
   (OI), recessive dystrophic epidermolysis bullosa (RDEB)
Irish setter + Progressive retinal atrophy rod cone dysplasia 4* (RCD4)
  - Canine leukocyte adhesion deficiency type 1 (CLAD1), DM,
   globoid cell leukodystrophy (GCL), RCD1
Labrador retriever + Exercise induced collapse* (EIC), PRCD*, centronuclear myopathy (CNM)
  - HUU, narcolepsy (NA), X-linked myotubular myopathy (XLMTM)
Papillon  +  Progressive retinal atrophy (PRA), von Willebrandt disease type 1 (VWD1)
Rottweiler - DMD-R, mucopolysaccharidosis I (MPS I)
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followed by gel electrophoresis. The same PCR mix 
as described for the PCR-sequencing was made. After 
the PCR, the product was loaded on a 2%-agarose gel. 
The fragment lengths can be viewed in Table 1.
PCR-RFLP
For mutations creating or destroying a restriction 
enzyme recognition site, a PCR-restriction fragment 
length polymorphism (PCR-RFLP) was performed. 
The same PCR mix was made as described for PCR-
sequencing. Subsequently, the product was digested 
by a restriction enzyme, cutting either the Wt or the 
Mt allele. The restriction digest was done overnight 
with 5 U of enzyme according to the instructions 
of Bioké, Leiden, the Netherlands. The end product 
was loaded onto a 3%-agarose gel, and the fragment 
lengths can be viewed in Table 1.
qPCR with dual labeled probes
A mix was made according to the descriptions in 
part 1. The mix was put in the Bio-Rad CFX96 C100 
TouchTM Thermal Cycler real-time PCR, resulting 
in an amplification curve and a melting curve. The 
annealing temperature for each test is mentioned in 
Table 1. 
RESULTS AND DISCUSSION
In total, 26 tests were performed. Three different 
breed specific tests were used for Duchenne type mus-
cular dystrophy (DMD) in the Cavalier King Charles 
spaniel, the Golden retriever and the Rottweiler. In 
Table 2, the tested disorders for each breed are shown. 
An overview of all tests, for which at least one mutant 
allele was found, can be viewed in Table 3. In case 
no mutant allele or a low mutant allele frequency was 
found, routine genotyping for this disorder is not ad-
vised by the authors. It should be noted that in the cases 
where the mutant allele in the population studied 
was not found, the allele might however be present 
in the Belgian population, especially in the breeds, of 
which only a relatively small number of animals were 
sampled. In case of precedents in a family or line, it 
should be considered to test for the disorder anyway. 
By making a deliberate partner choice, based on the 
genotyping results, creation of affected animals can 
be prevented and the mutant allele frequency can be 
reduced, without (further) endangering of the genetic 
diversity.
Bichon frise
The Bichon frise (n = 27) was genotyped for two 
disorders. X-linked hypohydrotic ectodermal dyspla-
sia (XHED), an X-linked trait of the ectoderm, usually 
characterized by the absence of hair follicles and skin 
glands, has been described previously in the Bichon 
frise in only one case report (Moura and Cirio, 2004). 
No mutant allele was found in the tested population. 
No other cases have been reported as of yet and no 
frequency data is available. It can be assumed that the 
mutant allele frequency is low to very low and maybe 
even absent in the Belgian population. However, the 
results should be interpreted with care given the small 
sample size.
Degenerative myelopathy (DM) is a late-onset pro-
gressive neurodegenerative disease with an autosomal 
recessive mode of inheritance (Zeng et al., 2014). Two 
carriers (Wt/Mt) were found in the sample, which in-
dicates a mutant allele frequency of 3.7% (Table 3). 
The Orthopedic Foundation for Animals (OFA) geno-
Table 3. Overview of the DNA tests per breed, for which at least one mutant allele was found with the total number of 
dogs tested (Total), the number of homozygous normal (Wt/Wt), heterozygous (Wt/Mt) and affected (Mt/Mt) individu-
als and the corresponding mutant allele frequency (q).
Breed Test Total Wt/Wt Wt/Mt Mt/Mt q (%)
Bichon frise DM 27 25 2 0 3.7
Bloodhound DM 27 14 13 0 24.1
Bouvier des Flandres EIC 101 94 7 0 3.5
 ST 102 97 5 0 2.5
Boxer ARVC 50 41 8 1 10
 DM 51 44 7 0 6.9
Cavalier King Charles spaniel EFS 57 50 7 0 6.1
 MTC 58 25 24 15 46.6
Golden retriever GR-PRA1 85 73 12 0 7.1
 PRCD 92 85 5 2 4.9
Irish setter RCD4 86 52 27 7 23.8
Labrador retriever CNM 143 141 2 0 0.7
 EIC 143 103 32 8 16.8
 PRCD 134 103 26 5 13.4
Papillon PRA 39 36 3 0 3.8
 VWD1 39 37 2 0 2.6
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typed six Bichon frise dogs and found one homozy-
gous mutant (Mt/Mt) animal. The Bloodhound and 
Boxer were also genotyped for DM (see below).
Bloodhound
For the Bloodhound population (n = 27), only 
DM was tested. A mutant allele frequency of 24.1% 
was found (Table 3). No homozygous mutant and 13 
heterozygous animals were found, creating a disequi-
librium in the H-W equilibrium. Fifteen point six 
normal (Wt/Wt) dogs, 9.8 carriers (Wt/Mt) and 1.6 
affected (Mt/Mt) animals are expected in an ideally 
balanced population. The disequilibrium is probably 
due to the small sample size and not due to (sample) 
selection bias as DM is a late-onset disorder. Frequen-
cy measurements have been performed in the USA. 
Zeng et al. (2014) found a mutant allele frequency of 
30.0%, which is in line with the findings of the present 
study, and the OFA found an even higher mutant al-
lele frequency of 44.0% (n = 311). However, the latter 
is probably an overestimation due to a selection bias 
of the sample tested. Despite the H-W disequilibrium, 
results of the present study indicate a very high fre-
quency in the Belgian population, as was the case in 
the USA population. Due to the high frequency and 
the severity of the disorder, routine testing should be 
encouraged.
Bouvier des Flandres
The Belgian population of the Bouvier des Flan-
dres was tested for the presence of the mutation caus-
ing exercise induced collapse (EIC) and that of a short 
tail (ST) (n = 101 and n = 102, respectively). The for-
mer is an autosomal recessive neuromuscular disor-
der, first discovered in the Labrador retriever (see also 
part 1) (Minor et al., 2011). A mutant allele frequency 
of 3.5% was found in this study for the Bouvier des 
Flandres (Table 3). No information on frequency else-
where is available as of yet.
The first causative mutation for “short tail” was 
found in the Pembroke Welsh corgi. This mutation 
is autosomal dominant and the mutation is lethal in 
the homozygous form (Haworth et al., 2001). An in-
nate short tail occurs in many dog breeds and this 
same mutation was found in several of these breeds 
(Hytönen et al., 2009). In the present study, it was 
tested if this mutation is also present in the Bouvier 
des Flandres. Out of 102 dogs, the five dogs that were 
born with a short tail, were genotyped as Wt/Mt (Ta-
ble 3), indicating this mutation is also responsible for 
or at least one of the causal mutations for the short 
tail phenotype in the Bouvier des Flandres. None of 
the other dogs, which had a normal tail length, carried 
the mutation. A short tail is neither a desirable nor an 
unattractive property according to the breed standards 
of the Bouvier des Flandres, so Belgian breeders gen-
erally do not breed in favor of this trait. Genotyping 
for ST is uncalled-for, since heterozygotes are pheno-
typically identifiable.
Boxer
Two tests were performed for the Boxer, namely 
arrhythmogenic right ventricular cardiomyopathy 
(ARVC) and degenerative myelopathy (DM). The 
presence of a mutant allele was confirmed in the stud-
ied population for both disorders.
Arrhythmogenic right ventricular cardiomyopathy 
is a serious and lethal heart condition that is associ-
ated with a dominant mutation in the STRN gene. The 
penetrance (the percentage of individuals carrying 
the mutation that also expresses the associated phe-
notype) of this mutation was estimated to be 100% 
for homozygotes and 82% for heterozygotes (Meurs 
et al., 2013). A far lower penetrance (although it could 
not be reliably calculated) was recently estimated in 
the UK by Cattanach et al. (2015). They suggested 
that the STRN mutation is not the cause, but is closely 
linked to the causal mutation. Pedigree analysis pin-
pointed the source of ARVC in the UK to a small 
number of breeding animals imported from America, 
but the STRN mutation had already been present in 
the UK population. The indigenous population, with 
no ancestry to the USA, is largely free of the disease. 
There may be a link between STRN homozygosity 
and more severe symptoms (Cattanach et al., 2015). 
A mutant allele frequency of 10.0% was found in 
the Belgian population of Boxers (n = 50) (Table 3). 
No frequency data is available from other countries. 
Given the high frequency, routine genotyping in 
breeding dogs is recommended and given the sever-
ity of this disease, non-breeding dogs should also be 
considered for testing. However, it should be stressed 
that due to the incomplete penetrance, not all animals 
carrying the mutation, will develop the disease.
Fifty-one Boxers were tested for DM and 13.7% 
were found to be heterozygous dogs (Table 3). These 
results are similar to the ones of a recent study, which 
reported 13.0% carriers out of 15 tested Boxers for 
DM (Broeckx et al., 2013). The OFA tested 2987 
Boxers for DM and found a much higher percentage 
of 35.9% carriers (Wt/Mt) and 45.9% affected (Mt/
Mt) animals. This is however not a randomized study, 
since the samples are derived from animals presented 
in the clinic, though the percentage is still a high one. 
It is advised for the Boxer to be routinely genotyped 
for DM. 
Cavalier King Charles spaniel
The Cavalier King Charles spaniel was genotyped 
for three disorders. Duchenne muscular dystrophy 
(DMD-C) is a lethal X-linked recessive muscle dis-
order (Walmsley et al., 2010). The causal mutation 
(Walmsley et al., 2010) is different from the one 
found in the Rottweiler (Winand et al., 1994) and in 
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the Golden retriever (Sharp et al., 1992), which will 
both be discussed later. No mutant allele was found in 
the tested population (n = 58) and no frequency deter-
minations have been performed in other populations 
as of yet. 
The autosomal recessive disorder episodic falling 
syndrome (EFS) causes neurological episodes often 
triggered by stress, excitement or exercise. Symptoms 
occur at the age of three months to four years and 
become progressively worse. A frequency of 12.3% 
(Wt/Mt) carriers was found in 57 genotyped animals, 
which is very similar to the estimate of 12.9% carriers 
in a USA population (Gill et al., 2011). No homozy-
gous mutant individuals were encountered (Table 3). 
The authors encourage routine genotyping in breed-
ing dogs because of the high frequency.
Macrothrombocytopenia (MTC) is an autosomal 
intermediate inheriting trait in the Cavalier King 
Charles spaniel. Animals with this mutation have 
a shortage of platelets and may potentially develop 
problems in the primary hemostasis. Heterozygotes 
have less thrombocytes than homozygous normal ani-
mals, but homozygous mutant animals have an even 
bigger shortage. This disorder is not a disease per se, 
since affected animals do not usually have bleeding 
tendencies. The main problem is situated in unneces-
sary treatments with antibiotics or corticosteroids, 
which are often given because of the abnormal blood 
parameters (Davis et al., 2008). In the genotyped popu- 
lation of the Cavalier King Charles spaniel of this 
study, a large mutant allele frequency of 46.6% was 
estimated (15.9% homozygous mutant and 41.4% 
heterozygous dogs) (Table 3). This is similar to the 
one found by Davis et al. (2008). They genotyped a 
Dublin population (n = 40) and found 12.5% homo-
zygous mutants and 52.5% heterozygotes. In the same 
study, an even larger percentage (47.0% homozygous 
mutant and 45.0% heterozygous dogs) was found in 
a USA population (n = 60). In view of the very high 
percentage, the authors recommend routine genotyp-
ing in all dogs in order to prevent wrongful medicinal 
use.
Irish setter
Of the five disorders the Irish setter was geno-
typed for, only progressive retinal atrophy rod-cone 
dysplasia 4 (RCD4) was present in the tested Belgian 
population. Canine leukocyte adhesion deficiency 
type 1 (CLAD1) is an autosomal recessive disease 
of the immune system, giving animals a low immune 
response against all sorts of infections, often leading 
to death (Kijas et al., 1999). Eighty-five Irish setters 
were tested for this disorder and no mutant allele was 
found. When the causal mutation was described for 
the first time, a frequency of 4.5% was found (Kijas et 
al., 1999). A follow-up study was performed, in which 
they found a mutant allele frequency of 3.2% in the 
Belgian population of Irish setters. The mutation was 
found in all ten countries included in the study (Kijas 
et al., 2000). Other studies estimated mutant allele 
frequencies between 7.6% and 13.0% in the USA 
(Foureman et al., 2002), 7.6% in Australia (Jobling et 
al., 2003) and 11.0% in Germany (Pfeiffer and Brenig, 
2005). The frequency of the CLAD-mutation in the 
Belgian population has apparently been reduced to 
near zero during the last 15 years, which is proof of 
the efficiency of using DNA-testing to decrease ge-
netic disorders. 
Eighty-six dogs were genotyped for DM, but no 
mutant allele was found in the Belgian population 
(n = 86). According to the OFA DM is present in the 
Irish setter. They estimated a mutant allele frequency 
of 14.3% in the USA population (n = 14). However, 
the selection bias (animals presented in the animal 
clinic and small population size) should be taken into 
account. 
Globoid cell leukodystrophy (GCL) is a fatal auto-
somal recessive lysosomal storage disease. The causal 
mutation was not found in the tested population (n = 
86). Three carriers were found in a sample of 24 Irish 
setters in the USA (McGraw and Carmichael, 2006).
Progressive retinal atrophy rod cone dysplasia 1 
and 4 (RCD1 and 4) are autosomal recessive disorders 
resulting in a degeneration of the retina. The former 
is an early-onset disorder (Suber et al., 1993), while 
the latter is a late-onset trait (Downs et al., 2013). The 
causal mutation for RCD1 was not found in any of 
the 86 genotyped Irish setters. A frequency determina-
tion for RCD1 was performed in the USA, where they 
found 7.8% heterozygotes (Aguirre et al., 1999). This 
disorder was tested on Belgian Irish setters in the past 
years to try and decrease the mutant allele frequency, 
which was effectively obtained. For RCD4, 31.4% 
carriers, 8.1% affected animals and a mutant allele 
frequency of 23.8% were found (Table 3). The muta-
tion causing this disorder is spread worldwide in Irish 
setters at a high frequency. In the UK and the USA, a 
study found 41.0% carriers and 8.3% affected animals 
(Downs et al., 2013). The results of the present study 
are well in line with these data. The high frequency 
might be explained by the fact that RCD4 is a late-
onset disease. The authors advise to routinely test for 
this disorder in animals used for breeding.
Papillon
The Papillon was genotyped for progressive reti-
nal atrophy (PRA) and von Willebrandt disease type 1 
(VWD1). The mutant allele was found in the tested 
population (n = 39) for both disorders. Progressive 
retinal atrophy is a degenerative eye condition that 
may lead to blindness and is transmitted in an auto-
somal recessive way (Ahonen et al., 2013). Three car-
riers (Wt/Mt) and no homozygous mutant individuals 
were found (Table 3). No frequency data is available 
as of yet in other populations. von Willebrandt dis-
ease type 1 is an autosomal recessive disorder of the 
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platelets that causes mild bleedings. These bleedings 
are the result of a decrease of von Willebrandt fac-
tor multimers, which are important for the adhesion 
of platelets to the endothelium (Boudreaux, 2012). 
A mutant allele frequency of 2.6% was found in the 
studied population (Table 3). No frequency determi-
nation is available in the literature for this condition. 
The results should be interpreted with care, given the 
small sample size. However,it can be concluded that 
both disorders are present in the Belgian population 
of the Papillon.
Rottweiler
Two DNA tests were performed for the Rottweiler, 
i.e. for genotyping DMD-R and mucopolysacchari-
dosis I (MPS I). Ninety-one dogs were genotyped 91 
for DMD-R, but the mutation was not found. There is 
no frequency data available as of yet in other popu-
lations. The lysosomal storage disease MPS I has an 
autosomal recessive mode of inheritance (Menon et 
al., 1992). The mutation was not detected in the geno-
typed population (n = 85) and no frequency data is 
available from other populations. It can be assumed 
that the prevalence of these two disorders in the Bel-
gian Rottweiler population is probably very low, and 
the mutation may even be absent.
Golden retriever
The Golden retriever was genotyped for a total 
of six disorders. No mutant allele was found in the 
Golden retriever sample (n = 91) for DM, indicating 
that the frequency in the Belgian population lies much 
lower and differs significantly from the one found by 
the OFA in the USA population. Three carriers and 
four Golden retrievers homozygous for the DM muta-
tion out of a population counting 185 dogs have been 
reported by OFA. A mutant allele frequency of 3.3% 
was calculated in another American population, in-
cluding 334 samples from a variety of sources (Zeng et 
al., 2014). However, there is a deviation of the Hardy- 
Weinberg equilibrium in both these studies. 
Duchenne muscular dystrophy (DMD-GR), a de-
generative muscle disease, has an X-chromosome 
linked recessive mode of inheritance (Sharp et al., 
1992). Other causal mutations have been described 
for the Cavalier King Charles spaniel (Walmsley et 
al., 2010) and the Rottweiler (Winand et al., 1994). 
The mutation was not found in the tested samples (n 
= 90) (Table 2). Nor did Broeckx et al. (2013) find 
the mutation in their population. No other frequency 
determinations have been performed as of yet.
Osteogenesis imperfecta (OI) probably has an auto- 
somal dominant mode of inheritance and is caused 
by a defective collagen type 1 fiber (Campbell et al., 
2000). In the Beagle, a mutation in another gene was 
found, resulting in the same defect, which implies 
that OI is genetically heterogeneous (Campbell et al., 
2001). The mutation was not found in the Belgian 
population (n = 90) and a frequency determination has 
not yet been performed elsewhere (Table 2).
For recessive dystrophic epidermolysis bullosa 
(RDEB), an autosomal recessive skin disorder caused 
by a defect in collagen type VII (Palazzi et al., 2000), 
the mutation was not found in the population of Gold-
en retrievers (n = 90), and no frequency data is avail-
able in other countries (Table 2).
Golden retriever progressive retinal atrophy 1 
(GR-PRA 1) is an autosomal recessive disorder caused 
by degeneration of photoreceptor cells in the retina 
(Downs et al, 2011). Being a genetic heterogenic trait 
in the Golden retriever, this mutation is only respon-
sible for part of the PRA cases in this breed, with an 
estimate of about 56.0% and varying from country to 
country. Twelve carriers were detected in the avail-
able samples (n = 85, q = 7.1%), giving a result in line 
with the frequency in the rest of Europe. Frequencies 
of 0.0% (USA), 2.0% (France), 4.0% (UK) and 6.0% 
(Sweden) have been described. The absence of the 
mutation in the USA suggests that the mutation origi-
nated in Europe (Downs et al., 2011). The authors ad-
vise to routinely genotype Golden retrievers used for 
breeding purposes for GR-PRA 1. 
Progressive rod cone degeneration (PRCD) is an 
autosomal recessive and late-onset photoreceptor de-
generation. The mutation is present in many breeds, 
including the Golden retriever and Labrador retriever 
(Zangerl et al., 2006). A total of 92 Golden retrie-
vers were genotyped and a mutant allele frequency 
of 4.9% was found. The percentage found in the 
Golden retriever was much lower than for the Labra-
dor retriever (see below). However, a mutant allele 
frequency of 4.9% is not low enough to be ignored. 
PCRD is preferably to be tested simultaneously with 
GR-PRA1. No frequency measurements have been 
performed as of yet in other countries. 
Labrador retriever
Six different tests were performed on the available 
Labrador retriever samples. No mutant allele was 
found in the available samples (n = 143) for HUU, 
narcolepsy (NA) and X-linked myotubular myopathy 
(XLMTM) (Table 2). Hyperuricosuria is present in the 
Labrador retriever, though at a very low prevalence 
(Karmi et al., 2010). For NA, an autosomal recessive 
sleeping disorder (Lin et al., 1999), no frequency data 
is available as of yet. Also for XLMTM, an X-linked 
recessive muscular defect, no frequency information 
is available so far (Beggs et al., 2010).
Centronuclear myopathy (CNM) is an autosomal 
recessive muscle disorder causing muscle weakness 
(Pelé et al., 2005). One hundred and forty-three Labra- 
dor retrievers were genotyped in this study and a 
low mutant allele frequency of 0.7% was calculated 
(Table 3). Maurer et al. (2012) genotyped over 7000 
Labrador retrievers in 13 countries. Mutant allele fre-
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quencies of 6.9% (Canada), 8.9% (USA) and 10.2% 
(UK and Ireland; Continental Europe) were found. 
It was also proven that some of the affected dogs in 
Germany and France were directly related to popular 
sires in the UK. The mutation probably originated in 
the UK and got spread to many other countries in the 
world (Maurer et al., 2012); however, as the results of 
the present study indicate, the mutation spread much 
less or only recently to the Belgian population. In line 
with the present results, Gentilini et al. (2011) esti-
mated a low frequency of 0.5% in Italy. Despite the 
low mutant allele frequency in Belgium, the authors 
advise to test Labrador retrievers for CNM, especially 
when they have ties to the UK population. 
Exercise induced collapse (EIC) is an autosomal 
recessive neuromuscular disorder characterized by 
exercise intolerance in otherwise healthy young adult 
dogs. Clinical signs are precipitated by heavy exercise 
(Minor et al., 2011). A percentage of 5.6% affected 
dogs and a high mutant allele frequency of 16.8% 
were found in the available samples (n = 143) for EIC 
(Table 3). Two independent studies in the USA esti-
mated a frequency of 3.0% affected dogs and 37.0% 
carriers (Patterson et al., 2008), and 9.9% affected 
dogs and 37.2% carriers (Minor et al. 2011), respec-
tively, which is in line with the results of the present 
study. Broeckx et al. (2013) found 29.0% affected ani-
mals and 25.0% carriers in a population of Labrador 
retrievers of Belgium, the Netherlands and Germany. 
This is a much higher percentage than the percentage 
of the present study and the one described by Minor 
et al. (2011). This huge difference in frequency and 
the deviation in the Hardy-Weinberg equilibrium in 
the study of Broeckx et al. (2013) may be explained 
by a bias caused by the fact that most samples were 
selected for a study involving hip dysplasia and 
mostly concerned show animals. The highest frequency 
of EIC in Labrador retrievers is indeed present in 
show/conformation dogs (Minor et al., 2011). The 
authors recommend to routinely genotype Labrador 
retrievers used for breeding for EIC.
The causal mutation of PRCD has been identi-
fied in many breeds, including the Labrador retriever 
(Zangerl et al., 2006). A mutant allele frequency of 
13.4% was found in the Belgian population tested (n 
= 134) (Table 3). There is no frequency data avail-
able in the literature as of yet. The high mutant allele 
frequency in the Labrador retriever may be explained 
by the late-onset of the defect, precluding selection 
against it. The authors encourage testing in order to 
(slowly) decrease the frequency.
GENERAL DISCUSSION AND CONCLUSION
No mutant allele was found for the X-linked traits 
(DMD-C, DMD-GR, DMD-R, XHED and XLMTM) 
which, as explained in part 1, may be due to their 
mode of inheritance.
The same logic should apply to dominant traits. 
Indeed, a similar conclusion may be reached for OI 
in the Golden retriever, an early-onset disorder with 
full penetrance. For the previously assumed partially 
dominant ARVC (Meurs et al., 2013) on the other 
hand, a high mutant allele frequency of 10.0% was 
found. However, Cattanach et al. (2015) recently 
showed that the STRN mutation is not the causal mu-
tation, but is only linked to the disorder. They also 
suggested a very low penetrance, close to the 20.0-
30.0% estimate seen in humans. This may partly ex-
plain the high frequency of the mutation.
The effectiveness of using a DNA-test to decrease 
the prevalence of hereditary disorders has been well 
demonstrated by CLAD and RCD1 in the Irish set-
ter. About 15 years ago, a mutant allele frequency of 
3.2% was found for CLAD in Belgium (Kijas et al., 
2000) and 7.8% heterozygotes were found in the USA 
for RCD1 (Aguirre et al., 1999). The routine genotyp-
ing for these disorders has probably led to the very 
low frequency in Belgium (no mutant alleles were 
found in this study).
A significant deviation was found to frequencies 
described in other populations for some disorders. 
The mutant DM allele was not found in the Golden re-
triever, while it was found in two USA populations at 
a frequency of 3.0-3.3% (OFA; Zeng et al., 2014). The 
mutation causing GR-PRA 1 in the Golden retriever 
was found at a frequency of 7.1% in the Belgian popu- 
lation and at similar frequencies in other countries 
in Europe, but was not found in a USA population 
(Downs et al., 2011), suggesting the mutation origi-
nated in Europe. The mutant allele frequency of CNM 
in the Golden retriever was calculated at 0.7%, while 
larger percentages were previously found in Canada 
(q = 6.9%), the USA (q = 8.9%), the UK and Ireland 
and Continental Europe (q = 10.2%) (Maurer et al., 
2012), proving that even within the same continent, 
there may be significant differences in occurrence.
Degenerative myelopathy was tested in the Bichon 
frise (q = 3.7%), the Bloodhound (q = 24.1%), the 
Boxer (q = 6.9%), the Irish setter (q = 0.0%) and the 
Labrador retriever (q = 0.0%) and RCD4 was tested 
in the Irish setter (q = 23.8%). These (fairly) high 
frequencies (except for DM in the Irish setter and 
Golden retriever) may be explained by the fact that 
both disorders are late onset. Often, affected animals 
have already sired offspring before they show clini-
cal signs, thus spreading the mutation. Degenerative 
myelopathy is present in a lot of breeds (see part 1). 
The OFA has already found the causal mutation in 88 
different dog breeds, one of which was a wolf hybrid.
A very high frequency was found for MTC in the 
Cavalier King Charles spaniel (q = 46.6%). The lack 
of symptoms may partly explain the high frequency. 
Another hypothesis is that the causal mutation is 
closely linked to a positive quality, thus selecting in 
favor of the MTC mutation, but this has yet to be 
tested.
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For five disorders (DM in the Bloodhound, EFS 
and MTC in the Cavalier King Charles spaniel, RCD4 
in the Irish setter and GR-PRA 1 in the Golden re-
triever), the results are in line with the frequency data 
reported in the literature. However, for the majority 
of the genotyped disorders, insufficient (DM in the 
Bichon frise), contradicting (EIC in the Labrador 
Retriever) or no frequency data (CN, EIC, ARVC, 
DMD-C, PRA, VWD1, DMD-R, DMD-GR, MPS 
I, OI, RDEB, PRCD, NA, XLMTM and HUU) was 
available, or the results did not correspond with the 
data found in the literature. This underscores the need 
of this type of studies to assist breeders in their en-
deavors to reduce the genetic load put on the popula-
tions by genetic diseases. Every year, more and more 
causal mutations are described. Frequency estima-
tions for these new variants as well as follow-up stud-
ies on the frequency of variants already described are 
necessary in order to be able to further decrease the 
prevalence of genetic disorders.
Disorders with a frequency high enough to warrant 
routine genotyping in breeding programs are DM for 
the Bloodhound and Boxer, ARVC for Boxers, EFS 
for the Cavalier King Charles spaniel, RCD4 for the 
Irish setter, GR-PRA1 in the Golden retriever and EIC 
and PRCD in the Labrador retriever. Macrothrombo- 
cytopenia should be tested in all Cavalier King Charles 
spaniels. Heterozygotes for these mutations and even 
homozygotes for the less severe disorders should not 
be routinely excluded from breeding programs, since 
this may lead to an even more important decrease in 
genetic diversity of breeds with an already (relatively) 
small genetic basis. Instead, the results of the geno-
typing should be used to make a well-reasoned part-
ner choice.
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